Rise of Fake GLP-1 Drug Ads Online: How to Spot Compounded Weight Loss Scams
If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight loss journey in a commercial for GLP-1 medications. Like millions of others, if you've ever considered taking these drugs, you probably searched online for information on availability and costs. Online searches for GLP-1 medications such as Ozempic and Wegovy have surged dramatically since 2022, with ads like Williams' Super Bowl spot both reflecting and driving this growing demand.
More and more advertisements for weight loss medications are appearing in daily life, often appearing appealing, intrusive, confusing, or even misleading. These ads have sparked widespread concerns about inappropriate use and adverse events. However, the high cost of GLP-1 medications, combined with inadequate insurance coverage, has fueled a booming online market for cheaper alternatives.
Not All GLP-1 Medications Are the Same
As of April 2026, the most popular GLP-1 medications approved by the Food and Drug Administration include semaglutide, sold under brand names like Wegovy, Ozempic, and Rybelsus; tirzepatide, sold as Mounjaro or Zepbound; and orforglipron, sold as Foundayo. These brand-name drugs have undergone rigorous clinical trials and extensive FDA evaluation, including reviews of clinical data, manufacturing processes, and facility inspections, to ensure safety, quality, and effectiveness.
Many GLP-1 drugs advertised online are not FDA-approved medications but rather "compounded" products made in compounding pharmacies. They contain the same active ingredients—such as semaglutide, tirzepatide, or orforglipron—but often include minor but clinically important modifications, like using different salt forms, adding various inactive ingredients, or varying drug concentrations or dosages. Additionally, they may be produced and stored under inconsistent quality standards.
Compounding pharmacies are intended to create personalized versions of FDA-approved medications to meet unique patient needs that mass-produced drugs cannot address. However, there is no evidence that modifications to GLP-1 medications sold by compounding pharmacies meet these criteria. Instead, companies are using compounding pharmacies to bypass FDA-approved manufacturers and generate profit.
FDA Warnings and Adverse Events
In February 2026, the FDA released a report alerting patients and providers about the risks of compounded GLP-1 medications. The report highlighted issues such as counterfeit Ozempic, the use of non-FDA-approved ingredients like retatrutide or cagrilintide, and products labeled as "not for human consumption" to bypass regulations.
As of July 2024, the most recent report, the FDA had received over 1,000 reports of adverse events related to compounded semaglutide and tirzepatide. These include gastrointestinal effects like nausea, vomiting, and abdominal pain, as well as fainting, headache, migraine, dehydration, acute pancreatitis, and gallstones. These effects occur because drug concentrations in compounded medications can vary significantly, leading to serious dosing errors.
Steps to Safely Obtain GLP-1 Medications Online
First, if you or someone you know is considering GLP-1 medications for weight management, it's crucial to understand that leading medical organizations have specific recommendations. For example, the American Diabetes Association only recommends GLP-1 drugs for weight loss for those with a body mass index of at least 30, or a BMI of 27 or greater if they have conditions like type 2 diabetes, hypertension, or high cholesterol. People with a BMI below 27 require further clinical evaluation.
If you and your doctor determine that GLP-1 medications are appropriate, avoid compounded versions unless specifically recommended by your healthcare provider. Identifying compounded drugs can be challenging, so carefully examine how medications are labeled on websites.
Websites selling compounded versions of GLP-1 drugs are not allowed to use FDA-approved brand names like Ozempic, Wegovy, and Zepbound. Look for red flags such as spelling errors or terms like "compounded," "generic version," or "same active ingredient as [brand name]." When in doubt, contact the online retailer to ask if the product is compounded.
Choosing Reliable Sources and Red Flags
If you decide to obtain GLP-1 medications online, choose reliable and transparent sources. Manufacturers of FDA-approved GLP-1 drugs provide official platforms like Novocare and LillyDirect, offering medication information, transparent pricing, and delivery options. Using these sources can reduce the risk of misleading ads or unverified products.
Online retailers offering GLP-1 drugs without requiring a prescription or medical evaluation are illegal and unsafe. Red flags include ads promoting easy prescriptions or only requiring an online form. Always start treatment by consulting with a local primary care provider who can evaluate your complete medical history.
Verify whether the pharmacy associated with the website is properly licensed and compliant with regulatory standards. Many online sellers use compounding pharmacies based outside the U.S. or without appropriate licenses. Check if the pharmacy has a physical U.S. address and telephone number, and confirm it is registered on the FDA database of approved compounded pharmacies and licensed by the state board of pharmacy.
Using unregistered or unlicensed pharmacies is highly unsafe and can lead to serious adverse effects. If the online retailer does not disclose the pharmacy, contact them for confirmation. After receiving medications, review the product and label carefully. Products without proper packaging, labeling, or expiration dates, or with foreign language on packaging, may be unsafe or unverified.
This article is based on research by health services experts Sujith Ramachandran, an Associate Professor of Pharmacy Administration at the University of Mississippi, and Liang-Yuan (Claire) Lin, a PhD Candidate in Pharmacy Administration at the same institution. It highlights the critical need for vigilance in the booming online market for weight loss drugs.
